UiPath builds and sells an integrated enterprise automation platform that combines traditional robotic process automation (PATH) Stock Forecast: What Could Drive It in 2026

Short answer

What is actually driving UiPath builds and sells an integrated enterprise automation platform that combines traditional robotic process automation (PATH) right now is Agentic Automation as the Next Growth Layer: UiPath is repositioning itself from an RPA vendor into what it calls a global leader in agentic automation, offering tools including Agent Builder, Agentic Orchestration, and UiPath Maestro for process intelligence. Revenue (FY2026, ended Jan 31, 2026) is ~$1.61 billion. If that keeps playing out, the setup is favourable; the risk to it is the central bear case is platform displacement: generative AI and agentic tools embedded into Microsoft 365, ServiceNow, and cloud hyperscaler platforms could allow enterprises to automate complex workflows without a dedicated RPA layer, gradually eroding UiPath's core value proposition. No one can predict where PATH trades, and Walnut does not publish targets, so treat this as a scenario, not a price target or prediction.

What could drive UiPath builds and sells an integrated enterprise automation platform that combines traditional robotic process automation (PATH) higher?

Agentic Automation as the Next Growth Layer

UiPath is repositioning itself from an RPA vendor into what it calls a global leader in agentic automation, offering tools including Agent Builder, Agentic Orchestration, and UiPath Maestro for process intelligence. Enterprises are moving from automation pilots into scaled, production deployments that require a trusted governance and orchestration layer. This transition could expand UiPath's addressable market well beyond traditional RPA if customers choose a unified platform rather than stitching together standalone AI tools.

Re-accelerating Revenue Growth with a Maturing Margin Profile

After a period of single-digit revenue growth, UiPath posted 13 percent full-year revenue growth in FY2026 and 17 percent year-over-year growth in Q1 FY2027, with $418 million in quarterly revenue. Simultaneously, the company achieved its first full-year GAAP operating profit and generated approximately $372 million in free cash flow in FY2026, indicating that revenue growth and profitability can coexist. Non-GAAP gross margins of 85 percent signal meaningful operating leverage as the company scales.

Large Installed Base and High Switching Costs

UiPath has over 8,500 enterprise customers globally and has been named a Leader in the Gartner Magic Quadrant for Robotic Process Automation for multiple consecutive years, as well as a Leader in Gartner's inaugural Magic Quadrant for Intelligent Document Processing. Its dollar-based net retention rate of 107 percent indicates that existing customers are modestly expanding their spending. Deep workflow integrations across mission-critical enterprise systems create meaningful switching costs and a relatively sticky revenue base.

Balance Sheet Strength and Capital Return

UiPath ended FY2026 with $1.69 billion in cash, cash equivalents, and marketable securities and essentially no debt, giving it substantial financial flexibility. The company authorized a new $500 million stock repurchase program following the completion of a prior $1 billion program, and it has been reducing its share count. A strong balance sheet provides runway for continued R&D investment and tuck-in acquisitions, such as the WorkFusion deal closed in early FY2027, without reliance on external capital markets.

What could weigh on PATH?

The central bear case is platform displacement: generative AI and agentic tools embedded into Microsoft 365, ServiceNow, and cloud hyperscaler platforms could allow enterprises to automate complex workflows without a dedicated RPA layer, gradually eroding UiPath's core value proposition. Competition from Automation Anywhere, Blue Prism, and emerging agentic AI startups intensifies pricing pressure and increases customer acquisition costs. UiPath's revenue growth has been inconsistent historically, and approximately 24 percent of its outstanding shares are sold short, reflecting meaningful market skepticism about whether the agentic pivot will translate into durable ARR acceleration. Insider selling, including by founder Daniel Dines, has also weighed on investor sentiment.

How to think about a PATH forecast

Rather than chasing a price target, it tends to help to weigh the drivers above against the risks, decide how long you are willing to hold, and size the position so a wrong call is survivable. A “forecast” is really a probability-weighted view of those drivers playing out, not a number.

For the full picture, see the PATH guide and whether PATH is a buy. In Walnut you can pressure-test the thesis against your real portfolio.

The bottom line on the PATH outlook

The bottom line: what is driving UiPath builds and sells an integrated enterprise automation platform that combines traditional robotic process automation (PATH) is Agentic Automation as the Next Growth Layer, with revenue (fy2026, ended jan 31, 2026) at ~$1.61 billion. If that keeps playing out the setup is favourable; the risk is the central bear case is platform displacement: generative AI and agentic tools embedded into Microsoft 365, ServiceNow, and cloud hyperscaler platforms could allow enterprises to automate complex workflows without a dedicated RPA layer, gradually eroding UiPath's core value proposition. No one can predict the price, so treat any PATH forecast as a scenario, not a target or prediction, and decide from your own thesis and time horizon. Walnut is not an investment adviser.

Build a basket around PATH with Walnut

Use UiPath builds and sells an integrated enterprise automation platform that combines traditional robotic process automation as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.

FAQ

What is the forecast for UiPath builds and sells an integrated enterprise automation platform that combines traditional robotic process automation (PATH)?

+

No one can reliably predict where PATH will trade, and Walnut does not publish price targets. What is more useful is the setup: the drivers that could push UiPath builds and sells an integrated enterprise automation platform that combines traditional robotic process automation higher and the risks that could weigh on it. This page lays out both so you can form your own view. Not a recommendation.

What could drive PATH higher?

+

The main growth drivers are Agentic Automation as the Next Growth Layer; Re-accelerating Revenue Growth with a Maturing Margin Profile; Large Installed Base and High Switching Costs. Whether they play out is the real question, not a guaranteed path.

What are the risks to PATH?

+

The central bear case is platform displacement: generative AI and agentic tools embedded into Microsoft 365, ServiceNow, and cloud hyperscaler platforms could allow enterprises to automate complex workflows without a dedicated RPA layer, gradually eroding UiPath's core value proposition. Competition from Automation Anywhere, Blue Prism, and emerging agentic AI startups intensifies pricing pressure and increases customer acquisition costs. UiPath's revenue growth has been inconsistent historically, and approximately 24 percent of its outstanding shares are sold short, reflecting meaningful market skepticism about whether the agentic pivot will translate into durable ARR acceleration. Insider selling, including by founder Daniel Dines, has also weighed on investor sentiment.

Will PATH stock go up in 2026?

+

Nobody knows, and anyone who says they do is guessing. UiPath builds and sells an integrated enterprise automation platform that combines traditional robotic process automation's direction depends on whether the drivers above outweigh the risks, plus the broader market. Focus on the thesis and your time horizon rather than a single-year call.

Is PATH a buy?

+

That depends on your thesis, time horizon, and what you already own, not on a forecast. See the PATH "is it a buy?" page for a framework. Walnut is not an investment adviser.

How has UiPath's stock performed and what has driven it lower?

+

PATH's stock has declined roughly 37 percent year-to-date as of mid-2026 and is well below its 2021 IPO-era highs. The decline reflects a combination of factors: a period of slower revenue growth after the post-COVID automation spending surge, investor concern that generative AI and agentic tools from Microsoft and others could erode UiPath's core RPA market, inconsistent earnings execution, and a broader re-rating of high-multiple software stocks. Insider selling by the founder has also been noted.

Walnut is informational, not investment advice. This page describes drivers and risks; it is not a price forecast, target, or recommendation. Markets are uncertain and past performance does not predict future results.

Related stocks

    UiPath builds and sells an integrated enterprise automation platform that combines traditional robotic process automation (PATH) Stock Forecast: What Could Drive It in 2026, Walnut